🔔 After the Bell
🎯 Session Review
Monday closed with a market that could not make up its mind. The S&P 500 slipped 0.28% to 7,652.86 and the Nasdaq dropped 0.76% to 25,980.19, while the Dow Jones bucked the trend with a modest 0.26% gain to 53,417.16. That divergence tells you something important: this was a tech problem, not a broad market collapse.NVIDIA led the Nasdaq lower, falling $6.24 to $208.48 as chip fatigue continued to weigh on the sector. Applied Optoelectronics (AAOI) had an even rougher session, shedding $17.19, or nearly 14%, signaling that enthusiasm for AI-adjacent plays is getting selective fast.
On the bright side, Visa (V) was a standout gainer, jumping $11.40 to $382.44 and helping prop up the Dow. Bitcoin also climbed 1.23% to $78,714, offering a small refuge for risk-on investors who still have appetite for something speculative.
📊 Today's Market Movers
|
▲ Gainers
|
▼ Losers
|
Your Phone Is Smarter Than Your Inbox
Not every market move can wait. Our text alerts deliver the ones that can't. One short alert, straight to your phone, when something is worth seeing now. No fluff. No noise. No charge.
Text Me the Alerts🚀 Key Catalysts
The headline that had retail investors doing a double take came from Target (TGT). The company publicly apologized and pulled a Halloween clown costume from shelves after widespread backlash that the design evoked Blackface and minstrel imagery. For a retailer already fighting to rebuild trust with consumers, the timing is rough, and the optics are worse heading into what should be a lucrative Halloween selling season.On the legal front, Guardant Health (GH) took a serious hit after a U.S. court ordered the company to pay $245.2 million to TwinStrand Biosciences and the University of Washington for infringing DNA sequencing patents. That kind of judgment does not just sting the balance sheet, it raises real questions about the company's core technology pipeline.
Meanwhile, Regenxbio (RGNX) cratered 22% after the company disclosed nodules and masses found on the spines of patients enrolled in its gene therapy trial for Hunter syndrome. Clinical-stage biotech is always a high-wire act, and today RGNX reminded everyone exactly why.
Sponsored Content
The SpaceX IPO Wasn't For You
The insiders got rich from SpaceX years before you could touch it.
But just one mile from SpaceX's launchpad, a tiny company is doing something SpaceX can't.
Robert Kiyosaki calls it The Shadow SpaceX.
The man he calls his "Financial 007" found it first.
It still trades under $7.
The institutions have not moved in yet. But they will.
🎭 Investor Mood
Investor Pulse: Cautiously Scattered
The mood today was cautious but not panicked. Treasury yields eased slightly across the board, with the 10-year dipping to 4.70% and the 30-year settling at 5.23%. That small move lower in yields gave the Dow some breathing room, even as growth stocks continued to face selling pressure.Geopolitical tension added a layer of unease to the session. The U.S. is set to announce new Iran sanctions in what officials are calling an Economic D-Day, with Treasury Secretary Scott Bessent targeting further isolation of Tehran from global financial markets. Energy traders and macro investors are paying close attention to how aggressively these sanctions get structured.
On the political side, a financial disclosure revealed that President Trump purchased up to $50,000 in SpaceX shares in June, giving the sitting president a direct financial stake in a major government contractor. That kind of overlap tends to generate questions that linger longer than one news cycle.
A storm is coming [ad]
🔍 5 Focus Points for Tomorrow
| 📋 | Watch Dell earnings closely as analysts expect results to test the 235% year-to-date rally |
| 📈 | Monitor DraftKings for any updates on prediction market court rulings that could shift sentiment |
| 📊 | Track Guardant Health after the $245M patent ruling and assess whether further legal exposure exists |
| ⛽ | Keep an eye on the Iran sanctions announcement and its potential ripple across energy and dollar markets |
| 🥇 | India's weakening monsoon is a slow-burn macro risk worth watching for agricultural commodity exposure |
Sponsored Content
3 AI Stocks to Buy in August 2026
He bought Apple in 1996. Nvidia at 66 cents split-adjusted. Amazon and Netflix under $3. Now Alexander Green says he's identified three AI stocks he believes could be the most profitable investments of the next decade. These aren't household names yet. That's the point. The window to get in early is open right now.
💸 Bottom Line
Dell (DELL) is one of the more interesting stories building into this week. The stock is up 235% year to date, and analysts say earnings have the potential to push it even higher. That is an enormous bar to clear, and the market will be watching closely to see if the AI infrastructure boom that has powered Dell's server business can continue at this pace.DraftKings (DKNG) is another name worth monitoring. Sports betting stocks have been under pressure from growing competition by prediction markets, but analysts suggest favorable court rulings could provide a meaningful catalyst for DKNG shares. Regulatory outcomes in this space tend to move fast and move stocks even faster.
India's monsoon situation deserves a spot on your macro radar too. With rainfall tracking roughly 15% below the long-term average, the weakest showing since 2009, agricultural commodity markets could see ripple effects on food prices globally. When the world's most populous country has a weather problem this significant, it rarely stays contained.
📰 Further Reading
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (Ad)
A small Colorado company now owns rights to a tech that could save the entire public power grid from collapse. And billionaire Sam Altman is now an investor.
Click here to learn this company's name for free.
AI insiders stockpile guns, gold & gas masks (Ad)
Silicon Valley billionaires are hoarding guns, gold, and military-grade gas masks. Some are fleeing the country entirely. A tech insider who has spent over $17 million on AI says he knows exactly why, and calls what's coming a "bloodbath." Before August 31st, he says there is one urgent move to make...
See exactly where to move your money
Trump's Dollar Reset (Ad)
Porter Stansberry believes President Trump is set to unveil a radical monetary reset at the G20 Summit in Miami, one already signed through executive order 14241. He argues this shift could draw a sharp line between those who prepare now and those who are left behind. His new documentary details thr...
Get the full story – and the five stocks to own now